KR20080105048A - 면역조절 화합물 및 염증성 사이토킨의 과생성에 관련된 질병의 치료 - Google Patents

면역조절 화합물 및 염증성 사이토킨의 과생성에 관련된 질병의 치료 Download PDF

Info

Publication number
KR20080105048A
KR20080105048A KR1020087020919A KR20087020919A KR20080105048A KR 20080105048 A KR20080105048 A KR 20080105048A KR 1020087020919 A KR1020087020919 A KR 1020087020919A KR 20087020919 A KR20087020919 A KR 20087020919A KR 20080105048 A KR20080105048 A KR 20080105048A
Authority
KR
South Korea
Prior art keywords
integer
cooh
amino
alkanoyloxy
mice
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020087020919A
Other languages
English (en)
Korean (ko)
Inventor
쟈끄 보에르
꺄를로 샤바롤리
스떼판 무뗄
Original Assignee
옴 파르마
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 옴 파르마 filed Critical 옴 파르마
Publication of KR20080105048A publication Critical patent/KR20080105048A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020087020919A 2006-03-09 2007-03-09 면역조절 화합물 및 염증성 사이토킨의 과생성에 관련된 질병의 치료 Ceased KR20080105048A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IBPCT/IB2006/050748 2006-03-09
IBPCT/IB2006/050748 2006-03-09

Publications (1)

Publication Number Publication Date
KR20080105048A true KR20080105048A (ko) 2008-12-03

Family

ID=38475231

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087020919A Ceased KR20080105048A (ko) 2006-03-09 2007-03-09 면역조절 화합물 및 염증성 사이토킨의 과생성에 관련된 질병의 치료

Country Status (14)

Country Link
US (3) US7915240B2 (cg-RX-API-DMAC7.html)
EP (1) EP2051728A4 (cg-RX-API-DMAC7.html)
JP (1) JP5341526B2 (cg-RX-API-DMAC7.html)
KR (1) KR20080105048A (cg-RX-API-DMAC7.html)
CN (1) CN101511379A (cg-RX-API-DMAC7.html)
AU (1) AU2007222135B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0708363A2 (cg-RX-API-DMAC7.html)
CA (1) CA2645053A1 (cg-RX-API-DMAC7.html)
IL (1) IL192837A (cg-RX-API-DMAC7.html)
MX (1) MX2008011360A (cg-RX-API-DMAC7.html)
NO (1) NO20084195L (cg-RX-API-DMAC7.html)
RU (1) RU2498813C2 (cg-RX-API-DMAC7.html)
WO (1) WO2007102081A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200806266B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8466456B2 (en) 2009-12-24 2013-06-18 Samsung Display Co., Ltd. Organic light-emitting display device and method of manufacturing the same

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007222135B2 (en) 2006-03-09 2012-02-02 Om Pharma Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines
US10065978B2 (en) 2015-11-24 2018-09-04 University Of South Carolina Cysteine-modifying substrate analogue inhibitors of ribose 5-phosphate isomerase for parasitic diseases, along with methods of their formation and use
US10682359B2 (en) 2017-03-31 2020-06-16 University Of South Carolina Inhibitors of glucose kinases, along with methods of their formation and use
US11059842B2 (en) 2019-04-29 2021-07-13 University Of South Carolina Monosaccharide amine and 3-nitro-2-phenyl-2H-chromene based inhibitors of glucose kinases
US11555047B2 (en) 2019-10-31 2023-01-17 University Of South Carolina One-step synthesis of phosphate-based inhibitors and applications thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ293584B6 (cs) * 1996-01-23 2004-06-16 Icn Pharmaceuticals Prostředek pro modulaci exprese lymfokinů
JP4305662B2 (ja) * 1996-09-30 2009-07-29 大塚製薬株式会社 サイトカイン産生抑制剤及び接着抑制剤
SK284054B6 (sk) * 1996-10-16 2004-08-03 Icn Pharmaceuticals, Inc. Substituované triazolové nukleozidy, farmaceutický prostriedok s ich obsahom a ich použitie
EP1027926B1 (en) 1997-08-04 2004-03-17 Teijin Limited Process for the preparation of aromatic carbonates
IT1296985B1 (it) * 1997-12-19 1999-08-03 Zambon Spa Derivati benzazinici inibitori della fosfodiesterasi 4
EP1081132B1 (en) * 1998-05-22 2004-03-10 Mitsubishi Pharma Corporation Hydroxamic acid derivatives and medicinal utilization thereof
SK287073B6 (sk) * 1998-06-30 2009-11-05 Om Pharma N-Acyldipeptidový derivát, spôsob jeho prípravy a farmaceutický prostriedok, ktorý ho obsahuje
US6831069B2 (en) 1999-08-27 2004-12-14 Ribapharm Inc. Pyrrolo[2,3-d]pyrimidine nucleoside analogs
AU1581400A (en) * 1999-12-22 2001-07-03 Om Pharma Acyl pseudopeptides bearing a functionalised auxiliary spacer
US20050192232A1 (en) * 1999-12-22 2005-09-01 Jacques Bauer Novel acyl-dipeptide-like compounds bearing an accessory functional side chain spacer, a method for preparing the same and pharmaceutical compositions containing such products
JP2003521928A (ja) * 2000-01-25 2003-07-22 ハイセック,インコーポレーテッド 前含脂肪細胞因子−1様(Pref−1様)ポリペプチドおよびポリヌクレオチドに関する方法と材料
JP2001316260A (ja) * 2000-02-29 2001-11-13 Meiji Milk Prod Co Ltd カバラクトン類を有効成分とするTNF−α産生抑制剤
DE20220947U1 (de) * 2001-02-28 2004-09-30 Ribapharm, Inc., Costa Mesa Pyrrolo2,3-dpyrimidin-Nucleosidanaloga
RU2190422C1 (ru) * 2001-04-25 2002-10-10 Кожемякин Леонид Андреевич Аэрозоль для ингаляций фармацевтической композиции глутовент и способ лечения с его использованием
JP4902913B2 (ja) * 2001-07-11 2012-03-21 森下仁丹株式会社 TNF−α産生抑制剤
JP2004107220A (ja) * 2002-09-13 2004-04-08 Mitsubishi Pharma Corp TNF−α産生抑制剤
JP2004256403A (ja) * 2003-02-25 2004-09-16 Kyowa Hakko Kogyo Co Ltd TNF−α産生抑制剤
MXPA05009500A (es) * 2003-03-07 2005-10-18 Kowa Co Derivado de benzofurano.
AU2007222135B2 (en) * 2006-03-09 2012-02-02 Om Pharma Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8466456B2 (en) 2009-12-24 2013-06-18 Samsung Display Co., Ltd. Organic light-emitting display device and method of manufacturing the same

Also Published As

Publication number Publication date
US7915240B2 (en) 2011-03-29
US20140086960A1 (en) 2014-03-27
BRPI0708363A2 (pt) 2011-05-24
RU2008139985A (ru) 2010-04-20
CA2645053A1 (en) 2007-09-13
JP5341526B2 (ja) 2013-11-13
US8618080B2 (en) 2013-12-31
NO20084195L (no) 2008-10-07
WO2007102081A3 (en) 2009-04-23
RU2498813C2 (ru) 2013-11-20
AU2007222135A1 (en) 2007-09-13
EP2051728A4 (en) 2010-03-31
MX2008011360A (es) 2009-03-03
AU2007222135B2 (en) 2012-02-02
US20120178721A1 (en) 2012-07-12
IL192837A (en) 2013-12-31
WO2007102081A2 (en) 2007-09-13
ZA200806266B (en) 2010-05-26
US20090054378A1 (en) 2009-02-26
EP2051728A2 (en) 2009-04-29
CN101511379A (zh) 2009-08-19
JP2009529523A (ja) 2009-08-20

Similar Documents

Publication Publication Date Title
AU2004206085B2 (en) Polyhydroxylated pyrrolizidine
US8618080B2 (en) Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines
EP0041896A1 (en) Immunologically active dipeptidyl 2-amino-1,2-dideoxy-D-glucose derivatives and methods of preparation
AU2005205962B2 (en) Immunomodulatory alkaloids
AU2004211850B2 (en) Remedy for viral disease
KR20150023536A (ko) 크로만 화합물
AU2010320558A1 (en) Use of macrocyclic lactone derivatives for the treatment of inflammatory disorders
TW202329920A (zh) 天冬氨酸的衍生物及其在肝纖維化、非酒精性肝炎等代謝等疾病的治療的應用
CN1222533C (zh) 作为细胞因子释放调节剂的棓单宁和鞣花单宁
HK1132660A (en) Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines
EP4458413A2 (en) A pharmaceutical composition and the use thereof in the treatment of autoimmune diseases
CN1098686C (zh) 黄嘌呤衍生物降低嗜酸性粒细胞的病理学高反应性的应用,黄嘌呤化合物及其制备方法
AU2012202597A1 (en) Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines
EP0545413A1 (en) Novel trans cyclopentanyl purine analogs useful as immunosuppressants
WO2024029528A1 (ja) アレルギー性疾患の改善用医薬組成物
US6495678B1 (en) Immunosuppressant containing glucopyranose derivative as active ingredient
WO2024130693A1 (zh) 精胺衍生物及其在疾病中的治疗用途

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20080826

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20120120

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20130704

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20140220

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20130704

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I